ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

35,763Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 387

$2.04M Total Retail Price of All Prescriptions

Rank: 4 out of 387

769 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 769 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 769 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 23,399 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 1,507 1,055 1 4
LISINOPRIL 1,136 729 2 3
FUROSEMIDE 1,093 873 3 7
SIMVASTATIN 1,069 648 4 5
HYDROCODONE-ACETAMINOPHEN 904 600 S3 5 1
LEVOTHYROXINE SODIUM 812 538 6 2
METOPROLOL TARTRATE 758 617 7 11
POTASSIUM CHLORIDE 633 504 8 9
AMLODIPINE BESYLATE 630 467 9 6
CITALOPRAM HBR 603 360 10 19
MIRTAZAPINE 598 539 11 64
TRAMADOL HCL 565 352 12 14
SERTRALINE HCL 534 345 13 23
ATORVASTATIN CALCIUM 525 387 14 13
GABAPENTIN 490 269 15 10
METFORMIN HCL 487 287 16 8
NAMENDA 461 218 17 35
FLUTICASONE PROPIONATE 429 258 18 29
DONEPEZIL HCL 403 342 19 27
ZOLPIDEM TARTRATE 330 198 20 16
CARBIDOPA-LEVODOPA 324 238 21 104
ESCITALOPRAM OXALATE 320 161 22 73
WARFARIN SODIUM 319 279 23 17
DIVALPROEX SODIUM 300 159 24 113
POLYETHYLENE GLYCOL 3350 294 186 25 57
RANITIDINE HCL 283 178 26 45
ALENDRONATE SODIUM 268 225 27 31
CLOPIDOGREL 266 178 28 25
MELOXICAM 261 181 29 22
TRAZODONE HCL 244 124 30 37
AZITHROMYCIN 243 183 31 49
KLOR-CON M20 231 216 32 76
LOVASTATIN 229 127 33 36
LOSARTAN POTASSIUM 223 188 34 24
NEXIUM 222 146 35 26
CARVEDILOL 220 152 36 21
SPIRIVA 217 97 37 61
GLIPIZIDE 216 154 38 63
RISPERIDONE 214 135 39 70
OLANZAPINE 213 101 40 126
IBUPROFEN 209 99 41 85
CLOZAPINE 206 59 42 185
ADVAIR DISKUS 205 139 43 41
QUETIAPINE FUMARATE 202 109 44 88
LEVETIRACETAM 201 131 45 110
METOPROLOL SUCCINATE 201 164 45 18
LANTUS 196 160 47 51
PRAVASTATIN SODIUM 186 152 48 15
METOCLOPRAMIDE HCL 180 143 49 125
PLAVIX 176 122 50 39
LIPITOR 176 100 50 103
ENALAPRIL MALEATE 175 142 52 69
CIPROFLOXACIN HCL 171 108 53 56
PANTOPRAZOLE SODIUM 169 109 54 48
CLONIDINE HCL 169 105 54 38
FAZACLO 165 0 56 191
HYDROCHLOROTHIAZIDE 164 136 57 12
PROAIR HFA 162 76 58 47
MEGESTROL ACETATE 160 145 R 59 123
ABILIFY 160 65 59 129
LAMOTRIGINE 160 27 59 138
COMBIVENT 155 86 62 133
CYCLOBENZAPRINE HCL 152 55 R 63 42
TOPIRAMATE 147 20 64 140
ALBUTEROL SULFATE 144 127 65 172
FAMOTIDINE 143 112 66 78
DIOVAN 142 113 67 33
FLUCONAZOLE 140 82 68 160
LOPERAMIDE 138 86 69 181
PHENYTOIN SODIUM EXTENDED 137 77 70 107
DICLOFENAC SODIUM 136 83 71 115
DIGOXIN 133 120 72 40
ISOSORBIDE MONONITRATE ER 127 108 73 59
ALLOPURINOL 124 98 74 28
ATENOLOL 124 85 74 20
DILTIAZEM HCL 123 115 76 187
OXYBUTYNIN CHLORIDE ER 122 90 77 120
NOVOLIN R 121 108 78 209
VENTOLIN HFA 121 53 78 142
FLUOXETINE HCL 117 53 80 46
CRESTOR 116 94 81 34
METOLAZONE 116 84 81 192
FENTANYL 115 98 S2 83 80
PREDNISONE 114 72 84 43
PROMETHAZINE HCL 113 65 R 85 82
CLOTRIMAZOLE-BETAMETHASONE 111 79 86 206
NOVOLOG 109 89 87 116
LACTULOSE 108 29 88 153
TAMSULOSIN HCL 106 69 89 32
VALPROIC ACID 103 49 90 243
VENLAFAXINE HCL ER 102 73 91 97
DIVALPROEX SODIUM ER 100 37 92 143
OXYBUTYNIN CHLORIDE 99 46 93 134
SEROQUEL 96 55 94 174
AMOX TR-POTASSIUM CLAVULANATE 91 52 95 131
AMITRIPTYLINE HCL 91 69 R 95 62
PAROXETINE HCL 91 31 95 52
LEXAPRO 90 47 98 227
DETROL LA 88 54 99 178
LYRICA 88 63 99 66
JANUVIA 87 54 101 60
IPRATROPIUM-ALBUTEROL 86 80 102 212
NITROGLYCERIN PATCH 84 74 103 242
GLIPIZIDE ER 84 71 103 137
BENAZEPRIL HCL 82 65 105 86
SINGULAIR 82 56 105 83
DOXAZOSIN MESYLATE 79 70 107 75
NOVOLIN 70-30 77 71 108 257
TIZANIDINE HCL 77 20 108 127
CYMBALTA 77 57 108 44
GEMFIBROZIL 77 40 108 93
ZIPRASIDONE HCL 75 65 112 292
LITHIUM CARBONATE 75 0 112 267
BACLOFEN 73 21 114 154
CALCIUM ACETATE 73 30 114 326
CEFADROXIL 72 40 116 285
GLYBURIDE-METFORMIN HCL 71 67 R 117 161
ACTOS 71 35 117 99
HYDRALAZINE HCL 71 59 117 94
PRENATAL PLUS 71 20 117 198
BUSPIRONE HCL 70 40 121 121
DESMOPRESSIN ACETATE 70 0 121 287
CELEBREX 70 53 121 72
HALOPERIDOL 70 32 121 253
NABUMETONE 69 26 125 117
VENLAFAXINE HCL 67 56 126 207
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 54 127 90
BENZTROPINE MESYLATE 65 38 R 128 167
PROPRANOLOL HCL 64 48 129 100
NAPROXEN 64 31 129 89
TRAVATAN Z 63 59 131 200
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 38 131 30
NITROFURANTOIN 62 54 133 261
PREMARIN 61 59 R 134 77
SUCRALFATE 59 25 135 128
ROPINIROLE HCL 58 37 136 91
SANTYL 58 52 136 190
ONGLYZA 57 15 138 298
LATANOPROST 57 46 138 258
HUMULIN N 56 54 140 269
DOXYCYCLINE HYCLATE 56 33 140 114
AMIODARONE HCL 56 47 140 156
MEDROXYPROGESTERONE ACETATE 55 12 143 230
TRIAMCINOLONE ACETONIDE 55 36 143 159
PERMETHRIN 54 0 145 291
GLIPIZIDE XL 54 43 145 232
GENERLAC 53 50 147 272
LOVAZA 52 22 148 211
MONTELUKAST SODIUM 52 28 148 152
PIOGLITAZONE HCL 51 17 R 150 305
HYDROXYZINE HCL 50 31 R 151 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.